Current Vascular Pharmacology

Publisher： Bentham Science Publishers

Founded in： 2003

Total resources： 75

E-ISSN： 1875-6212

ISSN： 1570-1611

Subject： R5 Internal Medicine

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Vascular Pharmacology

Menu

NAFLD-NASH: An Under-Recognized Epidemic

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 209-213

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 269-275

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 276-288

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Meet Our Editorial Board Member

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 205-205

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 219-227

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 298-305

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Vitamin D Levels in Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 289-297

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 254-268

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 206-208

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications

Current Vascular Pharmacology , Vol. 16, Iss. 3, 2018-03 , pp. 214-218

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 ... 103 Next Display item(s) per page Total 1025 item(s)